The first major update since 2003 was announced this week during the 2017 American Heart Association Scientific Sessions.
On Monday, the American Heart Association (AHA) and the American College of Cardiology unveiled new clinical guidelines for treating hypertension, marking the first major update since 2003. Hypertension, which occurs when there is too much pressure of blood against the walls of the arteries, is the second leading cause of heart disease after smoking. The new guidelines will have a ripple effect across healthcare, changing treatment protocols, data reporting, and whether practices and health systems are succeeding in population health. Here are 5 things to know about the new hypertension guidelines:
For more from the 2017 American Heart Association Scientific Sessions, visit our conference page at ajmc.com.
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More